- Home
- AWH vs AMIX Comparison
AWH vs AMIX Comparison
Compare AWH & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWH
- AMIX
- Stock Information
- Founded
- AWH 1993
- AMIX 2014
- Country
- AWH United States
- AMIX United States
- Employees
- AWH N/A
- AMIX N/A
- Industry
- AWH Medical/Dental Instruments
- AMIX
- Sector
- AWH Health Care
- AMIX
- Exchange
- AWH Nasdaq
- AMIX NYSE
- Market Cap
- AWH 2.9M
- AMIX 5.5M
- IPO Year
- AWH N/A
- AMIX N/A
- Fundamental
- Price
- AWH $0.15
- AMIX $2.05
- Analyst Decision
- AWH Buy
- AMIX
- Analyst Count
- AWH 2
- AMIX 0
- Target Price
- AWH $4.40
- AMIX N/A
- AVG Volume (30 Days)
- AWH 10.9M
- AMIX 31.4K
- Earning Date
- AWH 03-27-2025
- AMIX 02-13-2025
- Dividend Yield
- AWH N/A
- AMIX N/A
- EPS Growth
- AWH N/A
- AMIX N/A
- EPS
- AWH N/A
- AMIX N/A
- Revenue
- AWH $8,963,000.00
- AMIX N/A
- Revenue This Year
- AWH $11.87
- AMIX N/A
- Revenue Next Year
- AWH $79.10
- AMIX N/A
- P/E Ratio
- AWH N/A
- AMIX N/A
- Revenue Growth
- AWH N/A
- AMIX N/A
- 52 Week Low
- AWH $0.12
- AMIX $2.02
- 52 Week High
- AWH $3.81
- AMIX $82.00
- Technical
- Relative Strength Index (RSI)
- AWH 30.23
- AMIX 30.71
- Support Level
- AWH $0.12
- AMIX $2.24
- Resistance Level
- AWH $0.36
- AMIX $2.68
- Average True Range (ATR)
- AWH 0.04
- AMIX 0.21
- MACD
- AWH 0.01
- AMIX -0.04
- Stochastic Oscillator
- AWH 14.00
- AMIX 1.98
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.